Achieving Successful Outcomes in STEMI Patients: Keys to Optimizing Results

Journal Supplement

NACCME

Sponsored by North American Center for Continuing Medical Education, LLC

Presenters

Sameer Mehta, MD - Chair
Voluntary Associate Professor of Medicine
University of Miami Miller School of Medicine
President, Indo American Society of Interventional Cardiology
Miami, Florida

Roxana Mehran, MD
Columbia University Medical Center
Associate Professor of Medicine
Director of Outcomes Research
Data Coordination & Analysis for the Center for Interventional Vascular Therapies
Cardiovascular Research Foundation
Director of Data Coordinating & Analysis Center
New York, New York

Dean Kereiakes, MD, FACC
Medical Director
The Christ Hospital
Heart and Vascular Center/The Linder Center
Professor of Medicine, Ohio State University
Cincinnati, Ohio

Samin Sharma, MD, FACC
Director, Cardiac Catheterization Laboratory & Intervention
Zena & Michael A. Weiner Professor of Medicine / The Mount Sinai Medical Center
The Mount Sinai Medical Center
Division of Cardiology
New York, New York

Target Audience

This activity is designed for interventional cardiologists, emergency physicians,clinical cardiologists, cardiac and vascular surgeons, emergency department staff, critical care nurses, cardiovascular laboratory technologists and nurses, first responders, and hospital administrators.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

Discuss the role of a dual antiplatelet therapeutic approach in patients with acute coronary syndromes
Apply STEMI medication protocols for inter-hospital transfer
Compare the safety and efficacy of dual antiplatelet therapy and primary PCI for STEMI
Review limitations and potential adverse clinical events of dual-antiplatelet therapy in a variety of patient subsets
Review and apply the latest study results in determining the best available options of antithrombotic therapy within the clinical practice
Compare and contrast the net clinical findings within the high risk patient population

Activity Overview

This accredited journal supplement is available in PDF format.

To be eligible for documentation of credit, participants must read all monograph content, complete the post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.
There is no fee associated with this activity.

Release Date: May 1, 2010

Expiration Date: May 1, 2011

Estimated time to complete: 2 hours

For questions regarding this activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

CME Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NACCME designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association. Provider #: 110-3-E-06.

This continuing nursing education activity was approved by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

This continuing nursing education activity was approved for 2 contact hour(s).

Provider approved by the California Board of Registered Nursing, Provider #13255 for 2 contact hour(s).

AHRA Accreditation

Approved for 1 Category A, ARRT continuing education credits.

Independent Clinical Reviewer

Robert S. Dieter, MD, RVT
Loyola University Medical Center
Vascular and Endovascular Medicine
Interventional Cardiology
Assistant Professor of Medicine
Section of Cardiovascular Medicine
Maywood, Illinois

Planning Committee

The planning committee comprises Sameer Mehta, MD, Roxana Mehran, MD, Samin Sharma, MD, FACC and Dean Kereiakes, MD, FACC; Rich Keenan, Lindsay Mazzagatti, and Trish Levy, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Dr. Mehran: Research/grant support—BMS, Sanofi-Aventis and Bracco
Dr. Mehta has disclosed no relevant relationships with any commercial interest
Dr. Stone: Grant/research support—Atrium and Therox; Advisory Board—Boston Scientific, and Abbott Vascular; Honoraria—Bristol Myers Squibb and Astra Zeneca
Dr. Kereiakes: Consultant-- Eli Lilly & Co., Boston Scientific, Abbott Vascular, Cordis/Johnson & Johnson, REVA Medical; Promotional Speakers' Bureau, Eli Lilly & Co.; The Lindner Center receives research grant support from: Abbott Vascular, Cordis /Johnson & Johnson, Boston Scientific, Medtronic and Daiichi Sankyo
Dr. Sharma has disclosed no relevant relationships with any commercial interest
Clinical Reviewer: Dr. Dieter has disclosed no relevant relationships with any commercial interest
Editor: Renee Polvino: no relevant financial relationships with any commercial interest.

Planning Committee members Rich Keenan, Lindsay Mazzagatti, and Trish Levy have reported no relevant financial relationships with any commercial interest.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed that no off-label/unapproved use(s) of drugs and/or devices will be discussed.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2010 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC.